M&A Deal Summary

St. Jude Medical Acquires Irvine Biomedical

On October 7, 2004, St. Jude Medical acquired medical products company Irvine Biomedical

Acquisition Highlights
  • This is St. Jude Medical’s 4th transaction in the Medical Products sector.
  • This is St. Jude Medical’s 3rd transaction in the United States.
  • This is St. Jude Medical’s 3rd transaction in California.

M&A Deal Summary
Date 2004-10-07
Target Irvine Biomedical
Sector Medical Products
Buyer(s) St. Jude Medical
Deal Type Add-on Acquisition

Target

Irvine Biomedical

Irvine, California, United States
Irvine Biomedical, Inc. (IBI) an Irvine, California, privately held company which develops electrophysiology (EP) catheter products that are used by physician specialists to diagnose and treat cardiac rhythm disorders.

Search 193,103 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

St. Jude Medical

Saint Paul, Minnesota, United States

website

Category Company
Founded 1976
Sector Medical Products
Employees18,000
Revenue 5.5B USD (2016)
DESCRIPTION
Entrance to St. Jude Medical's corporate headquarters in St. Paul, Minnesota.
Entrance to St. Jude Medical's corporate headquarters in St. Paul, Minnesota.

St. Jude Medical, Inc. is a medical device manufacturer dedicated to transforming the treatment of most expensive, epidemic diseases. St. Jude Medical five major areas of focus that include heart failure, atrial fibrillation, neuromodulation, traditional cardiac rhythm management and cardiovascular. St. Jude Medical was formed in 1976 and is based in St. Paul, Minnesota.

DEAL STATS #
Overall 4 of 18
Sector (Medical Products) 4 of 17
Type (Add-on Acquisition) 4 of 17
State (California) 3 of 7
Country (United States) 3 of 15
Year (2004) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2002-09-17 Getz Bros.

Tokyo,, Japan

Getz Bros. Co. Ltd. is a Distributor of medical products in Japan. Company distributes cardiac surgery products and a majority of the Company's pacemaker products.

Buy $220M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2005-01-13 Endocardial Solutions

Saint Paul, Minnesota, United States

Endocardial Solutions, Inc. develops Minimally invasive technology for the diagnosis of abnormal heart rhythms.

Buy $272M
Mergr

Product

Company

Legal